Wanted: experts to sit on startups’ scientific advisory boards
Wu Xinyi
HOME-GROWN biotech startup Axcynsis Therapeutics is barely a year old, but has already appointed two eminent scientists to its scientific advisory board. Many other startups are seeking to do the same.
Amid rapid scientific advancements and a challenging funding environment, scientific advisory boards have emerged as indispensable assets for Singapore’s growing pool of biotech startups.
Biotech startups often face a lengthy and regulated process to commercialise their products or services, especially when making the leap from Singapore to other markets.
TRENDING NOW
MAS eases family office tax rules, widens AML checks as Singapore vies for global wealth
How BYD disrupted Singapore’s car market – and why the strategy is turning on itself
Vietnam seeks US$76 billion a year from capital markets to ease reliance on banks
SGX’s record year masks Singapore’s equities challenge